|Page (1) of 1 - 12/26/13||email article||print page|
Gilead Sciences' Sovaldi, for hepatitis C, was the most important new medicine approved this year. It heralds the hope that a viral disease that afflicts more than 3 million Americans, can be treated with a few pills-- or even one – and that doctors and scientists may be able to dramatically reduce the toll of the infection, which can cause liver failure and death.
|The Most Important New Drug Of 2013|
Source:GrabNetworks (c). All Rights Reserved